TopNews

Technical analyst Pankaj Jain of Satguru Capital is of the view that investors can sell Nitesh Estates stock in today's session to achieve a target of Rs 46.

According to Mr. Jain, the investors can sell the stock with a stoploss of Rs 53.

He also said that if the stock fell below Rs 42, it may see more weakness.

Today (May 14), the stock opened at Rs 50.20 on the Bombay Stock Exchange (BSE).

Nitesh Estates, which listed its shares on the stock markets on May 13, projects 12-monthly income of about 5k crore by the end of 2015.

Technical analyst Ashwani Gujral is of the view that investors can buy Whirlpool stock to achieve a target of Rs 230 in 1-2 trading sessions.

According to Mr. Gujral, the investors can buy the stock with a stop loss of Rs 195.

Today, the shares of the company opened at Rs 206.40 on the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 207.90 and a low of Rs 34.80 on BSE.

Current EPS & P/E ratio stood at 8.80 and 23.40 respectively.

According to the reports, Conservative Sarah Palin ripped an Illinois high school for canceling a trip by the girls basketball team to Arizona in protest of the state's immigration law.

The Chicago Tribune reported on Thursday that the former Alaska governor and 2008 Republican vice presidential candidate wondered aloud during a speech Wednesday in Chicago why the school wouldn't send the team to Arizona but allowed a student trip to China.

Technical Analyst Kunal Saraogi has maintained 'buy' rating on Mercator Lines to achieve an intraday target of Rs 58.

According to him, interested traders can purchase the stock with a stop loss of Rs 54.

The shares of the company, on May 13, closed at Rs 55.35 on the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 76.75 and a low of Rs 39 on BSE.

Current EPS & P/E ratio stood at 5.95 and 9.28 respectively.

Mercator Lines said that its full year earning declined 46% to $40.7 million.

Indian stock markets marked its closure on a positive noted on Thursday. The scrips in limelight were real estate, auto, consumer durables and healthcare, whereas metal and oil & gas topped the declining charts.

Midcap and small cap scrips also did to notch gains of 1.23% & 0.97% respectively.

The index also hit an intraday high of 17,389.15. Afterward, it shed the majority of its gains and came off from early highs to close on a positive note.

Aurobindo Pharma has declared that the US FDA has given tentative nod for Rosuvastatin Calclum pills in strengths of 5mg, 10mg, 20mg and 40mg.

According to the company, Resuvastatin Calclum tabs, which comes under cardio vascular (CVS) therapeutic family, treats high LDL cholesterol and total cholesterol level.

For the year ended Dec 31, 2009, Resuvastatin Calclum tabs hold a market size of $ 2.9 billion in the United States.